Related Experiment Video
Updated: May 9, 2026
10:27
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Summary
The GATOR complex, comprising GATOR1 and GATOR2, acts as a crucial inhibitor of amino acid sensing pathways involving RAG proteins and mTORC1 signaling.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Amino acid availability is a key regulator of cellular growth and metabolism.
- The mechanistic Target of Rapamycin Complex 1 (mTORC1) pathway integrates nutrient signals to control cell growth.
- The Rag GTPases (RAGs) mediate mTORC1 activation in response to amino acids.
Purpose of the Study:
- To elucidate the role of the GATOR complex in amino acid sensing.
- To investigate the inhibitory mechanism of GATOR on RAG GTPases and mTORC1 activation.
Main Methods:
- Biochemical assays to study protein-protein interactions.
- Cellular assays to monitor mTORC1 signaling.
- Genetic manipulation to assess the function of GATOR subunits.
Main Results:
- The GATOR complex, consisting of GATOR1 and GATOR2, was identified as a negative regulator of amino acid sensing.
- GATOR directly inhibits the activity of RAG GTPases.
- Disruption of GATOR function leads to constitutive mTORC1 activation, independent of amino acid levels.
Conclusions:
- The GATOR complex is a critical checkpoint in the amino acid-sensing pathway.
- GATOR1/2 subunits function to prevent aberrant mTORC1 signaling by inhibiting RAGs.
- Understanding GATOR's role provides insights into nutrient-dependent growth regulation.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...